FDA Approves First Therapy for Tumor-Induced Osteomalacia Hina Zahid19 Jun 2020 10:00 AM ISTThe U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia...
FDA approves Ilaris for treatment of active Still's disease Dr. Kamal Kant Kohli17 Jun 2020 8:21 AM ISTThe U.S. Food and Drug Administration has approved Ilaris (canakinumab) injection for the treatment of Active Still's disease, including Adult-Onset...
Don't administer remdesivir with HCQS or CQ, FDA warns of drug interaction Dr. Kamal Kant Kohli16 Jun 2020 12:45 PM ISTThe U.S. Food and Drug Administration has issued warning to health care providers about a newly discovered potential drug interaction related to the...
FDA withdraws emergency use status of CQ and HCQS in COVID 19 patients Dr. Kamal Kant Kohli15 Jun 2020 11:27 PM ISTFood and Drug Administration has revoked emergency use status of hydroxychloroquine in Covid 19 infection following a request from Gary Disbrow,...
FDA Approves Drug to Treat Infants and Children with HIV Hina Zahid14 Jun 2020 6:43 PM ISTThe U.S. Food and Drug Administration has approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1...
FDA approves Ineblizumab for rare autoimmune disease of CNS Dr. Kamal Kant Kohli12 Jun 2020 4:33 AM ISTThe US Food and Drug Administration (FDA) has approved inebilizumab-cdon injection (Uplizna) for treatment of neuromyelitis optica spectrum disorder...
FDA approves bronchoscopic therapy for COPD and Asthma Dr. Kamal Kant Kohli9 Jun 2020 8:42 AM ISTMINNEAPOLIS-The U.S. Food and Drug Administration (FDA) has granted approval to Nuvaira® Lung Denervation System for has been designation as a...
FDA Approves Antibiotic for nosocomial and ventilatilator associated bacterial Pneumonia Hina Zahid6 Jun 2020 11:41 AM ISTThe U S food and drug administration has approved antibiotic combination imipenem-cilastatin and relbactam (Recarbrio) for the treatment of...
FDA grants breakthrough designation to wearable device for Restless Legs Syndrome Dr. Kamal Kant Kohli5 Jun 2020 11:43 AM ISTSAN FRANCISCO - Noctrix Health, Inc., a privately held medical device company announced today that the US Food and Drug Administration (FDA) has...
FDA okays trial of novel allogenic cell therapy for COVID-19 linked ARDS Dr. Kamal Kant Kohli3 Jun 2020 4:45 PM ISTHOUSTON-- The US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood...
FDA approves drug for heavy menstrual bleeding due to fibroids Dr. Kamal Kant Kohli30 May 2020 7:43 AM ISTThe U.S. Food and Drug Administration has approved Oriahnn capsules for the management of heavy menstrual bleeding associated with uterine...
FDA Authorizes Self-Collection Kit for COVID-19 Nasal Specimen Hina Zahid29 May 2020 3:02 PM ISTSECAUCUS, N.J. -- The U.S. Food and Drug Administration (FDA) has granted emergency authorisation to Quest Diagnostics Self-collection Kit for...
